Latest News

  • RESEARCH

    19 Dec 2025

    A New Twist Makes mRNA Drugs More Selective

  • REGULATORY

    18 Dec 2025

    BARDA Pullback Signals New Phase for US mRNA Development

  • INNOVATION

    17 Dec 2025

    mRNA Design Enters a More Predictive Era

  • INVESTMENT

    15 Dec 2025

    Moderna Bets on Debt to Power mRNA’s Next Act

mRNA Finds a New Role in Personalised Cancer Care

Illustration of syringe targeting virus cell, symbolizing mRNA cancer vaccine research

INNOVATION

12 Dec 2025

Phase 2b melanoma data fuels interest in personalized mRNA vaccines, highlighting design agility while raising new questions about scale, cost, and broader efficacy

Icahn School of Medicine at Mount Sinai where researchers develop selective mRNA drug designs

RESEARCH

19 Dec 2025

A New Twist Makes mRNA Drugs More Selective

Preclinical US research in mouse models suggest redesigned mRNA activates mainly in diseased cells, hinting at safer drugs as human trials...

HHS press release signaling reduced BARDA support for mRNA development

REGULATORY

18 Dec 2025

BARDA Pullback Signals New Phase for US mRNA Development

HHS is winding down BARDA-backed mRNA vaccine programs, prompting analysts to see a shift toward commercially focused mRNA strategies

Aerial view of the University of Texas campus where new AI mRNA research was developed.

INNOVATION

17 Dec 2025

mRNA Design Enters a More Predictive Era

New AI research forecasts mRNA protein output earlier, helping developers refine drug designs before costly lab testing begins

Crowd gathered outside Moderna headquarters building in daylight

INVESTMENT

15 Dec 2025

Moderna Bets on Debt to Power mRNA’s Next Act

Moderna secures a $1.5B non-dilutive term loan to fund mRNA growth beyond COVID, highlighting why established players may prioritize long-...

Illustration of syringe targeting virus cell, symbolizing mRNA cancer vaccine research

INNOVATION

12 Dec 2025

mRNA Finds a New Role in Personalised Cancer Care

Phase 2b melanoma data fuels interest in personalized mRNA vaccines, highlighting design agility while raising new questions about scale, ...

Gloved hand prepares syringe with mRNA vaccine vial.

MARKET TRENDS

11 Dec 2025

The Post-Pandemic mRNA Push Gains Steam

Big players push mRNA into new arenas while early pipelines and selective deals shape the next wave

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.